1. Willan R: On Cutaneous Diseases. London, J. Johnson, 1808
2. Siemens HW: Die vererbung in der atiologie der hautkrankheiten. In: Handbuch der Haut- und Geschlechtskrankheiten, edited by J Jadassohn. Berlin, Springer, 1929, p. 1
3. Wells RS, Kerr CB: Genetic classification of ichthyosis. Arch Dermatol 92:1, 1965
4. Wells RS, Kerr CB: Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. Br Med J 1:947, 1966
5. Traupe H: The Ichthyoses: A Guide to Clinical Diagnosis, Genetic Counseling, and Therapy. Berlin, Springer-Verlag, 1989
6. Frost P, Van Scott EJ: Ichthyosiform dermatoses. Classification based on anatomic and biometric observations. Arch Dermatol 94:113, 1966
7. Williams ML, Elias PM: Gentically transmitted, generalized disorders of cornification. The ichthyoses. In: Dermatologic Clinics. The Genodermatoses, edited by JC Alper. Philadelphia, W.B. Saunders, p. 155, 1987
8. Arin MJ, Hohl D, Roop DR: Disorders of keratinization. In: Connective Tissue and Its Heritable Disorders, 2nd edition. edited by PM Royce, B Steinmann. Wiley, 2002, p. 1025
9. Oji V et al: Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Soreze 2009. J Am Acad Dermatol 63(4):607-641, 2010
11. DiGiovanna JJ, Bale SJ: Epidermolytic hyperkeratosis: Applied molecular genetics. Prog Dermatol 27:1, 1993
12. Huber M et al: Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 267:525, 1995
13. Russell LJ et al: Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat Genet 9:279, 1995
14. Nemes Z et al: A novel function for transglutaminase 1: Attachment of long-chain omega- hydroxyceramides to involucrin by ester bond formation. Proc Natl Acad Sci USA 96:8402, 1999
15. Farasat S et al: Novel transglutaminase-1 mutations and genotype-phenotype investigations of 104 patients with autosomal recessive congenital ichthyosis in the USA. J Med Genet 46:103, 2009
16. Shapiro LJ et al: X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet 1:70, 1978
17. Koppe G et al: X-linked icthyosis. A sulphatase deficiency. Arch Dis Child 53:803, 1978
18. Lefevre C et al: Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum Mol Genet 15:767, 2006
19. Chavanas S et al: Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141, 2000
20. Richard G et al: The spectrum of mutations in erythrokeratodermias–Novel and de novo mutations in GJB3. Hum Genet 106:321, 2000
21. Richard G et al: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet 70:1341, 2002
22. Smith FJ et al: Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38:337, 2006
23. Liao H et al: Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol 127(12):2795-2798, 2007
24. Gruber R et al: Increased pachyonychia congenita severity in patients with concurrent keratin and filaggrin mutations. Br J Dermatol 161:1391, 2009
25. Schmuth M, Elias PM, Williams ML: Pathogenesis of the barrier abnormalities in disorders of cornification. In: Skin Barrier, edited by PM Elias, KR Feingold. New York, Taylor & Francis, 2006, pp. 469
26. Mevorah B et al: Autosomal dominant ichthyosis and X-linked ichthyosis. Acta Derm Venereol Stockh 71:431, 1991
27. Palmer CN et al: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441, 2006
28. Brown SJ et al: Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: Further delineation of the skin phenotype in a prospective epidemiological study of 792 school children. Br J Dermatol 161:884, 2009
29. Cuevas-Covarrubias SA et al: Accuracy of the clinical diagnosis of recessive X-linked ichthyosis vs ichthyosis vulgaris. J Dermatol 23:594, 1996
30. Dale BA, Holbrook KA, Steinert PM: Assembly of stratum corneum basic protein and keratin filaments in macrofibrils. Arch Dermatol Res 276:729, 1978
31. Harding CR, Scott IR: Stratum corneum moisturising factors. In: Skin Moisturization, edited by J Leyden, A Rawlings. New York, Marcel Dekker, 2002, p. 61,
32. Sybert VP, Dale BA, Holbrook KA: Ichthyosis vulgaris: Identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 84:191, 1985
33. Sandilands A et al: Filaggrin in the frontline: Role in skin barrier function and disease. J Cell Sci 122:1285, 2009
34. van den Oord RA, Sheikh A: Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: Systematic review and meta-analysis. BMJ 339:b2433, 2009
35. Rose FA: Review: The mammalian sulphatases and placental sulphatase deficiency in man. J Inherit Metab Dis 5:145, 1982
36. Epstein EH Jr, Williams ML, Elias PM: Steroid sulfatase, X-linked ichthyosis, and stratum corneum cell cohesion. Arch Dermatol 117:761, 1981
37. Lykkesfeldt G, Nielsen MD, Lykkesfeldt AE: Placental steroid sulfatase deficiency: Biochemical diagnosis and clinical review. Obstet Gynecol 64:49, 1984
38. Merrett JD et al: Discriminant function analysis of phenotype variates in ichthyosis. Am J Hum Genet 19:575, 1967
39. Jay B, Blach RK, Wells RS: Ocular manifestations of ichthyosis. Br J Ophthalmol 52:217, 1968
40. Sever RJ, Frost P, Weinstein G: Eye changes in ichthyosis. JAMA 206:2283, 1968
41. Lykkesfeldt G, Bennett P, Lykkesfeldt AE et al: Testis cancer. Ichthyosis constitutes a significant risk factor. Cancer 67:730, 1991
42. Epstein EH Jr, Bonifas JM: Recessive X-linked ichthyosis: Lack of immunologically detectable steroid sulfatase enzyme protein. Hum Genet 71:201, 1985
43. Ballabio A et al: Deletion of the distal short arm of the X chromosome (Xp) in a patient with short stature, chondrodysplasia punctata, and X-linked ichthyosis due to steroid sulfatase deficiency. Am J Med Genet 41:184, 1991
44. Paige DG et al: A clinical and genetic study of X-linked recessive ichthyosis and contiguous gene defects. Br J Dermatol 131:622, 1994
45. Robledo R, Melis P, Schillinger E et al: X-linked ichthyosis without STS deficiency: Clinical, genetical, and molecular studies. Am J Med Genet 59:143, 1995
46. Simpson JR: Congenital Ichthyosiform Erythrodermia. Trans St Johns Hosp Dermatol Soc 50:93, 1964
47. Williams ML, Elias PM: Heterogeneity in autosomal recessive ichthyosis. Arch Dermatol 121:477, 1985
48. Bernhardt M, Baden HP: Report of a family with an unusual expression of recessive ichthyosis. Review of 42 cases. Arch Dermatol 122:428, 1986
49. Fischer J: Autosomal recessive congenital ichthyosis. J Invest Dermatol 129:1319, 2009
50. Hazell M, Marks R: Clinical, histologic, and cell kinetic discriminants between lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 121:489, 1985
51. Jacyk WK: Bathing-suit ichthyosis. A peculiar phenotype of lamellar ichthyosis in South African blacks. Eur J Dermatol 15:433, 2005
52. Oji V et al: Bathing suit ichthyosis is caused by transglutaminase-1 deficiency: Evidence for a temperature-sensitive phenotype. Hum Mol Genet 15:3083, 2006
53. Choate KA et al: Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 2:1263, 1996
54. Matsumoto K et al: Loricrin keratoderma: A cause of congenital ichthyosiform erythroderma and collodion baby. Br J Dermatol 145:657, 2001
55. Brash AR et al: The hepoxilin connection in the epidermis. FEBS J 274:3494, 2007
56. Brocq L: Erythrodermie congénitale ichthyosiforme avec hyperépidermotrophie. Ann Dermatol Syphiligr4,3:1, 1902
57. Cheng J et al: The genetic basis of epidermolytic hyperkeratosis: A disorder of differentiation-specific epidermal keratin genes. Cell 70:811, 1992
58. DiGiovanna JJ, Bale SJ: Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 130:1026, 1994
59. Paller AS et al: Genetic and clinical mosaicism in a type of epidermal nevus. N Engl J Med 331:1408, 1994
60. Nazzaro V et al: Epidermolytic hyperkeratosis: Generalized form in children from parents with systematized linear form. Br J Dermatol 122:417, 1990
61. Schmuth M et al: Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 117:837, 2001
62. Chipev CC et al: A leucine proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 70:821, 1992
63. Reis A et al: Keratin 9 gene mutations in epidermolytic paplmoplantar keratoderma (EPPK). Nat Genet 6:174, 1994
64. Rothnagel JA et al: Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nat Genet 7:485, 1994
65. Sprecher E et al: Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol 116:511, 2001
66. Sahn EE, Weimer CE Jr., Garen PD: Annular epidermolytic ichthyosis: A unique phenotype. J Am Acad Dermatol 27:348, 1992
67. Sybert VP et al: Cyclic ichthyosis with epidermolytic hyperkeratosis: A phenotype conferred by mutations in the 2B domain of keratin K1. Am J Hum Genet 64:732, 1999
68. Joh GY et al: A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol 108:357, 1997
69. Ozturk A et al: A retrospective study on 16 collodion babies. Turk J Pediatr 39:55, 1997
71. Frenk E, de Techtermann F: Self-healing collodion baby: Evidence for autosomal recessive inheritance. Pediatr Dermatol 9:95, 1992
72. Vahlquist A et al: Genotypic and clinical spectrum of self-improving collodion ichthyosis: ALOX12B, ALOXE3, and TGM1 mutations in Scandinavian patients. J Invest Dermatol 130:438, 2010
73. Waring JI: Early mention of a harlequin fetus in America. Am J Dis Child 43:442, 1932
74. Roberts LJ: Long-term survival of a harlequin fetus. J Am Acad Dermatol 21:335, 1989
75. Haftek M et al: A longitudinal study of a harlequin infant presenting clinically as non- bullous congential icthyosiform erythroderma. Br J Dermatol 135:448, 1996
76. Milner ME et al: Abnormal lamellar granules in harlequin ichthyosis. J Invest Dermatol 99:824, 1992
77. Kelsell DP et al: Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am J Hum Genet 76:794, 2005
78. Akiyama M et al: Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest 115:1777, 2005
79. Thomas
AC et al: ABCA12 is the major harlequin ichthyosis gene.
J Invest Dermatol 126(11):2408-2413, 2006
80. Lefevre C et al: Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum Mol Genet 12:2369, 2003
81. Altman J, Stroud J: Netherton's syndrome and ichthyosis linearis circumflexa. Arch Dermatol 100:550, 1969
82. Hurwitz S, Kirsch N, McGuire J: Reevaluation of ichthyosis and hair shaft abnormalities. Arch Dermatol 103:266, 1971
83. Stoll C et al: Severe hypernatremic dehydration in an infant with Netherton syndrome. Genet Couns 12:237, 2001
84. Powell J: Increasing the likelihood of early diagnosis of Netherton syndrome by simple examination of eyebrow hairs. Arch Dermatol 136:423, 2000
85. Renner ED et al: Comel-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 124:536, 2009
86. Walley AJ et al: Gene polymorphism in Netherton and common atopic disease. Nat Genet 29:175, 2001
87. Sprecher E et al: The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: Implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol 117:179, 2001
88. Allen A et al: Significant absorption of topical
tacrolimus in 3 patients with Netherton syndrome.
Arch Dermatol 137:747, 2001
89. Borzyskowski M, Grant DB, Wells RS: Cushing's syndrome induced by topical steroids used for the treatment of non-bullous ichthyosiform erythroderma. Clin Exp Dermatol 1:337, 1976
90. Jang JY et al: Clinical characteristics and VPS33B mutations in patients with ARC syndrome. J Pediatr Gastroenterol Nutr 48:348, 2009
91. Sprecher E et al: A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet 77:242, 2005
92. Srebrnik A et al: Dorfman-Chanarin syndrome. J Am Acad Dermatol 17:801, 1987
93. Lefevre C et al: Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 69:1002, 2001
94. Lass A et al: Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab 3:309, 2006
95. Herman GE: X-Linked dominant disorders of cholesterol biosynthesis in man and mouse. Biochim Biophys Acta 1529:357, 2000
96. Grange DK et al: CHILD syndrome caused by deficiency of 3beta-hydroxysteroid-delta8, delta7-isomerase [letter] [see comments]. Am J Med Genet 90:328, 2000
97. Konig A et al: Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet 90:339, 2000
98. Herman GE: Disorders of cholesterol biosynthesis: Prototypic metabolic malformation syndromes. Hum Mol Genet12(Spec No. 1):R75-R88, 2003
99. Happle R: X-linked dominant chondrodysplasia punctata. Hum Genet 53:65, 1979
100. Curry CJ et al: Inherited chondrodysplasia punctata due to a deletion of the terminal short arm of an X chromosome. N Engl J Med 311:1010, 1984
101. Hosenfeld D, Wiedemann HR: Chondrodysplasia punctata in an adult recognized as vitamin K antagonist embryopathy. Clin Genet 35:376, 1989
102. Motley AM et al: Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am J Hum Genet 70:612, 2002
103. Franco B et al: A cluster of sulfatase genes on Xp22.3: Mutations in chondrodysplasia punctata (CDPX) and implications for
warfarin embryopathy.
Cell 81:15, 1995
104. Kolde G, Happle R: Histologic and ultrastructural features of the ichthyotic skin in X-linked dominant chondrodysplasia punctata. Acta Derm Venereol (Stockh) 64:389, 1984
105. Becker K et al: Identification of a novel mutation in 3beta-hydroxysteroid-Delta8-Delta7-isomerase in a case of Conradi-Hunermann-Happle syndrome. Exp Dermatol 10:286, 2001
106. Krunic AL et al: Congenital reticular ichthyosiform erythroderma–ichthyosis variegata: A case report and review of the literature. Acta Derm Venereol 83:36, 2003
107. Choate KA, Lu Y, Zhou J et al: Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10. Science 330 (6000):94-97, 2010
108. Rogers M: Erythrokeratodermas: A classification in a state of flux? Australas J Dermatol 46:127, 2005
109. Richard G et al: Genetic heterogeneity in erythrokeratodermia variabilis: Novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations. J Invest Dermatol 120:601, 2003
110. Degos R, Delzant O, Morival H: Erytheme desquamatif en plaques, congenital et familial (genodermatose nouvelle?). Bull Soc Fr Dermatol Syphiligr 54:442, 1947
111. Landau M et al: Erythrokeratodermia variabilis with erythema gyratum repens-like lesions. Pediatr Dermatol 19:285, 2002
112. Kelly LJ, Kocsard B, Kocsard E: Congenital ichthyosis with erythema anulare centrifugum. A new form of ichthyosis affecting 12 members of a family of 31 in 5 generations. Dermatologica 140:75, 1970
113. Beare JM et al: Atypical erythrokeratoderma with deafness, physical retardation and peripheral neuropathy. Br J Dermatol 87:308, 1972
114. Giroux JM, Barbeau A: Erythrokeratodermia with ataxia. Arch Dermatol 106:183, 1972
115. Richard G et al: Linkage studies in erythrokeratodermias: Fine mapping, genetic heterogeneity and analysis of candidate genes. J Invest Dermatol 109:666, 1997
116. Richard G et al: Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis [see comments]. Nat Genet 20:366, 1998
117. Macari F et al: Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. Am J Hum Genet 67:1296, 2000
118. Darier MJ: Erythro-kératodermie verruqueuse en nappes, symétrique et progressive. Bull Soc Fr Dermatol Syphiligr 22:252, 1911
119. Ruiz-Maldonado R et al: Erythrokeratodermia progressiva symmetrica: Report of 10 cases. Dermatologica 164:133, 1982
120. Ishida-Yamamoto A et al: The molecular pathology of progressive symmetric erythrokeratoderma: A frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet 61:581, 1997
121. van Steensel M: Does progressive symmetric erythrokeratoderma exist? Br J Dermatol 150:1043, 2004
122. van Steensel MA et al: The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron. Am J Med Genet A 149A:657, 2009
123. Eramo LR et al: Ichthyosis follicularis with alopecia and photophobia. Arch Dermatol 121:1167, 1985
124. Megarbane H et al: Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome: Report of a new family with additional features and review. Am J Med Genet A 124:323, 2004
125. Happle R: What is IFAP syndrome? Am J Med Genet A 124:328, 2004
126. Oeffner F et al: IFAP syndrome is caused by deficiency in MBTPS2, an intramembrane zinc metalloprotease essential for cholesterol homeostasis and ER stress response. Am J Hum Genet 84:459, 2009
127. Bygum A, Westermark P, Brandrup F: Ichthyosis prematurity syndrome: A well-defined congenital ichthyosis subtype. J Am Acad Dermatol 59:S71-S74, 2008
128. Klar J et al: Mutations in the fatty acid transport protein 4 gene cause the ichthyosis prematurity syndrome. Am J Hum Genet 85:248, 2009
129. Caceres-Rios H et al: Keratitis, ichthyosis, and deafness (KID syndrome): Review of the literature and proposal of a new terminology. Pediatr Dermatol 13:105, 1996
130. Maestrini E et al: A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 8:1237, 1999
131. Jan AY et al: Genetic heterogeneity of KID syndrome: Identification of a Cx30 gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia. J Invest Dermatol 122:1108, 2004
132. Dahlqvist J et al: A single-nucleotide deletion in the
POMP 5′ UTR causes a transcriptional switch and altered epidermal proteasome distribution in KLICK genodermatosis.
Am J Hum Genet 86:596, 2010
133. Montpetit A et al: Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord. PLoS Genet 4:e1000296, 2008
134. Soong BW et al: Multiple sulfatase deficiency. Neurology 38:1273, 1988
135. Schmidt B et al: A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell 82:271, 1995
136. Dierks T et al: Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme. Cell 113:435, 2003
137. Cosma MP et al: The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell 113:445, 2003
138. Baala L et al: Homozygosity mapping of a locus for a novel syndromic ichthyosis to chromosome 3q27-q28. J Invest Dermatol 119:70, 2002
139. Hadj-Rabia S et al: Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: A tight junction disease. Gastroenterology 127:1386, 2004
140. Aras N et al: Peeling skin syndrome. J Am Acad Dermatol 30:135, 1994
141. Silverman AK et al: Continual skin peeling syndrome. An electron microscopic study. Arch Dermatol 122:71, 1986
142. Hashimoto K et al: Acral peeling skin syndrome. J Am Acad Dermatol 43:1112, 2000
143. Cassidy AJ et al: A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndrome. Am J Hum Genet 77:909, 2005
144. Mevorah B et al: Peeling skin syndrome with hair changes. Dermatology 197:373, 1998
145. Komatsu N et al: Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes. J Invest Dermatol 126(10):2338-2342, 2006
146. Davies MG et al: Epidermal abnormalities in Refsum's disease. Br J Dermatol 97:401, 1977
147. Kitareewan S et al: Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol Biol Cell 7:1153, 1996
148. Jansen GA et al: Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet 17:190, 1997
149. Wanders RJ, Jansen GA, Skjeldal OH: Refsum disease, peroxisomes and phytanic acid oxidation: A review. J Neuropathol Exp Neurol 60:1021, 2001
150. Jansen GA, Waterham HR, Wanders RJ: Molecular basis of Refsum disease: Sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7). Hum Mutat 23:209, 2004
151. Jagell S, Liden S: Ichthyosis in the Sjogren-Larsson syndrome. Clin Genet 21:243, 1982
152. Rizzo WB, Lin Z, Carney G: Fatty aldehyde dehydrogenase: Genomic structure, expression and mutation analysis in Sjogren-Larsson syndrome. Chem Biol Interact 130-132:297, 2001
153. DeLaurenzi V et al: Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat Genet 12:52, 1996
154. Rizzo WB, Carney G: Sjogren-Larsson syndrome: Diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum Mutat 26:1, 2005
155. Nigro JF, Rizzo WB, Esterly NB: Redefining the Sjogren-Larsson syndrome: Atypical findings in three siblings and implications regarding diagnosis. J Am Acad Dermatol 35:678, 1996
156. Price VH et al: Trichothiodystrophy: Sulfur-deficient brittle hair as a marker for a neuroectodermal symptom complex. Arch Dermatol 116:1375, 1980
157. Liang C et al: Characterization of tiger-tail banding and hair shaft abnormalities in trichothiodystrophy. J Am Acad Dermatol 52:224, 2005
158. Liang C et al: Structural and molecular hair abnormalities in trichothiodystrophy. J Invest Dermatol 126:2210, 2006
159. Faghri S et al: Trichothiodystrophy: A systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet 45:609, 2008
160. Happle R et al: The Tay syndrome (congenital ichthyosis with trichothiodystrophy). Eur J Pediatr 141:147, 1984
161. Jorizzo JL et al: Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature (IBIDS syndrome). Br J Dermatol 106:705, 1982
162. Rebora A, Crovato F: PIBI(D)S syndrome – Trichothiodystropy with xeroderma pigmentosum (group D) mutation. J Am Acad Dermatol 16:940, 1987
163. Nakabayashi K et al: Identification of C7orf11 (TTDN1) gene mutations and genetic heterogeneity in nonphotosensitive trichothiodystrophy. Am J Hum Genet 76:510, 2005
164. Okulicz JF, Schwartz RA: Hereditary and acquired ichthyosis vulgaris. Int J Dermatol 42:95, 2003
165. Patel N et al: Acquired ichthyosis. J Am Acad Dermatol 55:647, 2006
166. Schwartz RA, Williams ML: Acquired ichthyosis: A marker for internal disease. Am Fam Physician 29:181, 1984
167. Hodak E et al: Ichthyosiform mycosis fungoides: An atypical variant of cutaneous T-cell lymphoma. J Am Acad Dermatol 50:368, 2004
168. Goodman DS et al: Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 17:210, 1987
169. Kaplan MH et al: Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: A new association with intravenous drug abuse. J Am Acad Dermatol 29:701, 1993
170. Feind-Koopmans AG, Lucker GP, van de Kerkhof PC: Acquired ichthyosiform erythroderma and sarcoidosis. J Am Acad Dermatol 35:826, 1996
171. Humbert P, Agache P: Acquired ichthyosis: A new cutaneous marker of autoimmunity. Arch Dermatol 127:263, 1991
172. Cruz-Alvarez J, Allegue F, Oliver J: Acquired ichthyosis associated with eosinophilic fasciitis. J Am Acad Dermatol 34:1079, 1996
173. Spelman LJ et al: Acquired ichthyosis in bone marrow transplant recipients. J Am Acad Dermatol 35:17, 1996
174. Greist MC, Epinette WW: Cimetidine-induced xerosis and asteatotic dermatitis. Arch Dermatol 118:253, 1982
175. Caver CV: Clofazimine-induced ichthyosis and its treatment. Cutis 29:341, 1982
176. Kumar B, Saraswat A, Kaur I: Mucocutaneous adverse effects of
hydroxyurea: A prospective study of 30 psoriasis patients.
Clin Exp Dermatol 27:8, 2002
177. Williams ML et al: Ichthyosis induced by cholesterol-lowering drugs. Implications for epidermal cholesterol homeostasis. Arch Dermatol 123:1535, 1987
178. Baykal C, Kormkmaz Y, Kavak A: Lovastatin-induced, acquired ichthyosis. Eur J Dermatol 6:581, 1996
179. Norton SA, Ruze P: Kava dermopathy. J Am Acad Dermatol 31:89, 1994
180. Grimalt R et al: Pityriasis rotunda: Report of a familial occurrence and review of the literature. J Am Acad Dermatol 31:866, 1994
181. Montemarano AD et al: Confluent and reticulated papillomatosis: Response to
minocycline.
J Am Acad Dermatol 34:253, 1996
182. Davis MD, Weenig RH, Camilleri MJ: Confluent and reticulate papillomatosis (Gougerot-Carteaud syndrome): A minocycline-responsive dermatosis without evidence for yeast in pathogenesis. A study of 39 patients and a proposal of diagnostic criteria. Br J Dermatol 154:287, 2006
183. Fleckman P: Management of the ichthyoses. Skin Therapy Lett 8:3, 2003
184. DiGiovanna JJ, Robinson-Bostom L: Ichthyosis: Etiology, diagnosis, and management. Am J Clin Dermatol 4:81, 2003
185. Germann R et al: [Life threatening salicylate poisoning caused by percutaneous absorption in severe ichthyosis vulgaris]. Hautarzt 47:624, 1996
186. Nguyen V et al: Treatment of ichthyosiform diseases with topically applied
tazarotene: Risk of systemic absorption.
J Am Acad Dermatol 57:S123-S125, 2007
187. Moskowitz DG et al: Pathophysiologic basis for growth failure in children with ichthyosis: An evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. J Pediatr 145:82, 2004
188. Verfaille CJ et al: Oral liarozole vs.
acitretin in the treatment of ichthyosis: A phase II/III multicentre, double-blind, randomized, active-controlled study.
Br J Dermatol 156:965, 2007
189. Fassihi H, McGrath JA: Prenatal diagnosis of epidermolysis bullosa. Dermatol Clin 28:231, viii, 2010
190. Tabor A, Alfirevic Z: Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 27:1, 2010
191. Lebo RV et al: Prenatal in situ hybridization test for deleted steroid sulfatase gene. Am J Med Genet 46:652, 1993
192. Sarasin A et al: Prenatal diagnosis in a subset of trichothiodystrophy patients defective in DNA repair. Br J Dermatol 127:485, 1992